Aptamer Modifications Solutions

Creative Biolabs provides a comprehensive suite of aptamer modification solutions. Our modification platform is designed to overcome the inherent limitations of natural nucleic acids, ensuring that your aptamer candidates possess the necessary stability, affinity, and pharmacokinetic profiles for success.

Submit Your Request Now

Download our service brochure

Inquiry

Why Aptamer Modification Matters

Aptamer performance is governed not only by sequence but by chemical architecture. Without modification, even high-affinity aptamers may fail in real biological systems. Chemical modifications directly address these bottlenecks:

Enhanced nuclease resistance for serum, plasma, and cellular environments
Improved binding affinity and structural stability
Extended circulation half-life
Expanded compatibility with detection platforms and delivery systems
Controlled pharmacokinetics and biodistribution

Great Minds Choose Creative Biolabs

Our Aptamer Modifications Solutions are designed to optimize these parameters without compromising target recognition.

Partner with Us

Our Aptamer Modification Portfolio

Our platform covers a full spectrum of chemical and functional aptamer modifications, including the following dedicated service modules.

2'-Fluoro (2'-F) Modifications

The 2'-Fluoro modification is one of the most widely used strategies to enhance the nuclease resistance of RNA aptamers. By replacing the hydroxyl group (-OH) at the 2' position of the ribose with a fluorine atom, we significantly increase the metabolic stability of the oligonucleotide without compromising its binding affinity.

2'-Amino (2'-NH₂) Modifications

2'-Amino modifications involve the substitution of the 2'-OH group with an amino group. This modification not only provides robust protection against nuclease degradation but also introduces a reactive site for further conjugation with other functional groups or polymers.

2'-O-Methyl (2'-O-Me/OCH₃) Modifications

The 2'-O-Methyl modification is a naturally occurring modification that provides excellent stability and is generally well-tolerated by the immune system, reducing potential off-target effects or innate immune activation (TLR responses).

3'-Inverted Thymidine (3'-InvT) Modifications

To protect aptamers from 3'-to-5' exonuclease activity, which is the primary route of degradation in blood, Creative Biolabs offers 3'-inverted thymidine capping. This involves creating a 3'-3' phosphodiester linkage at the terminal end.

Fluorescence Modifications

For diagnostic applications, bio-imaging, and mechanism-of-action (MoA) studies, we provide a wide range of fluorescence labeling services. We can incorporate fluorophores at the 5', 3', or internal positions.

Biotin Modifications

Biotinylation is a powerful tool for the immobilization and purification of aptamers. By leveraging the ultra-high affinity of the biotin-streptavidin interaction, we enable a variety of downstream assays.

Discuss Your Needs

Our Aptamer Modification Strategy: Precision by Design

We apply a structure-guided and application-specific modification philosophy, rather than one-size-fits-all chemistry. This strategy ensures that modified aptamers remain functional, reproducible, and scalable.

Preserve binding motifs while reinforcing structural regions

Balance chemical stability and folding fidelity

Align modification density with downstream use

Validate performance experimentally, not theoretically

Start Your Project

Which Modification for Which Assay?

Application/Assay	Recommended Modifications	Why It Works
Serum stability testing	2'-F, 2'-O-Me, 3'-InvT	Resists nuclease degradation and terminal trimming
Cell surface binding (FACS)	Fluorescence + (2'-F or 2'-O-Me)	Signal readout + stability during incubation
Confocal / live-cell imaging	Fluorescence + stabilizing backbone	Preserves aptamer integrity for time-lapse studies
ELONA / plate-based detection	Biotin (± 3'-InvT)	Strong immobilization and consistent capture
Pull-down / target enrichment	Biotin + nuclease resistance	Improves capture robustness and sample handling
Biosensors / surface immobilization	Biotin or custom conjugation handle	Stable anchoring, reproducible kinetics
Competitive binding / inhibition assays	2'-F or 2'-O-Me	Improves aptamer persistence during competition

Design Your Workflow

Customization Options & Design Flexibility

Target class, binding mechanism, assay environment, and experimental timeline all influence how an aptamer should be modified. Our aptamer modifications solutions are therefore built around highly flexible customization pathways.

Single or Combinatorial Modification Strategies

Pairing 2'-fluoro substitutions with terminal inverted nucleotides
Integrating functional labels alongside nuclease-resistant backbones

Modification Positions Can be Precisely Controlled

At the 5'end
At the 3'end
At the internal nucleotides
At the selected structural regions

Support Application-specific Optimization

Adjusting modification density
Adjusting Chemistry type
Adjusting Linker length

Case Studies

Case 1

Graphene Oxide and Fluorescent-Aptamer-Based Novel Aptasensors

W3 is an aptamer that can specifically bind to mCRC cells with high affinity. Graphene oxide (GO) is a two-dimensional graphitic carbon nanomaterial, which has widely used in constructing biosensors. The researchers have developed a no-wash fluorescent aptasensor for one-step and sensitive detection of mCRC LoVo cells. GO can quench the green fluorescence of the FAM-labeled W3 (FAM-W3). In the presence of the target cells, FAM-W3 preferentially binds the target cells and detaches from the surface of GO, leading to the fluorescence of FAM recovery.

FAM-W3-GO for Cancer Cell Detection. (OA Literature) Fig.1 Schematic illustration represents the working principle of the GO-based fluorescent aptasensor assay.^1,2

References

Chen, Hang, et al. "Graphene oxide and fluorescent-aptamer-based novel aptasensors for detection of metastatic colorectal cancer cells." Polymers 14.15 (2022): 3040. https://doi.org/10.3390/polym14153040
Distributed under Open Access license CC BY 4.0, without modification.

What Our Clients Say

"We had previously tested unmodified aptamers in serum-based assays, but degradation was a constant issue. The modified aptamers provided by Creative Biolabs demonstrated markedly improved stability while maintaining binding performance, allowing us to generate consistent and reproducible data."

— Director of Assay Development, Biotechnology Company

"What impressed us most was not just the synthesis quality, but the upfront discussion around modification positioning. The team clearly understood how chemical changes could impact folding and affinity, which significantly reduced the risk on our side."

—Principal Investigator, Translational Research Laboratory

"We required fluorescently labeled aptamers that would perform reliably across flow cytometry and imaging platforms. The delivered materials integrated seamlessly into our existing workflows and showed excellent signal-to-noise characteristics."

— Senior Scientist, Cell Biology Research Group

"Compared with previous vendors, Creative Biolabs provided clearer guidance on selecting the most appropriate modification strategy instead of offering a generic solution. This saved us both time and experimental iterations."

— Program Lead, Academic-Industry Collaborative Project

FAQs

What types of aptamers can be modified through this service?

We support chemical modification of both DNA and RNA aptamers, including sequences generated through in-house discovery, published literature, or client-provided SELEX campaigns. Modification strategies are selected based on sequence composition, structural features, and intended application.

How do you ensure that chemical modifications do not compromise target binding?

Our design process prioritizes preservation of known or predicted binding regions. Modifications are preferentially introduced at terminal positions or structurally permissive regions, and optional binding validation can be performed to confirm functional integrity after modification.

Can you combine multiple modifications within a single aptamer?

Yes. We routinely design aptamers incorporating combinatorial modifications, such as nuclease-resistant backbones together with fluorescent or biotin labels. Each combination is evaluated for compatibility to balance stability, affinity, and assay performance.

Do you provide guidance on selecting the most appropriate modification strategy?

Scientific consultation is an integral part of this service. Our team works with clients to evaluate experimental conditions, assay duration, detection method, and downstream plans in order to recommend a modification strategy aligned with practical research needs.

Can modified aptamers be integrated into downstream assays upon delivery?

Yes. Aptamers are delivered in a research-ready format, accompanied by handling and storage recommendations. This allows clients to proceed directly to binding studies, functional assays, or platform integration without additional preparation steps.

How customizable is the service for non-standard applications?

The service is highly flexible. For projects with unique assay formats, conjugation requirements, or platform constraints, we can design customized modification schemes and discuss feasibility during the consultation phase.

What information should be prepared before initiating a project?

Providing the aptamer sequence, target information, and intended application is helpful. If some details are still under development, our scientists can assist in refining requirements and defining a practical modification pathway.